Clinical trial
The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
NCT00421278 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00421278 |
|---|---|
| Title | The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED) |
| Official title | A Clinical Study to Evaluate the Efficacy and Safety of MK0633 in Patients With Atherosclerosis |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atherosclerosis |
| Intervention type | Drug |
| Interventions | MK0633 |
| Enrollment | 180 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Jan 22, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: